a real world approach to ldl cholesterol using pcsk9 inhibitors, october 5 2018
Published 5 years ago • 16K plays • Length 52:04Download video MP4
Download video MP3
Similar videos
-
2:35
alirocumab – a pcsk9 inhibitor for high cholesterol
-
3:31
pcsk9 antibody dramatically lowers ldl
-
1:05:30
pcsk9 inhibition: lowering lipids and reducing cardiovascular events
-
46:28
ldl-c: how low should we go?
-
1:37:52
novel therapeutic strategies targeting pcsk9 for reducing ldl-c in hyperlipidemia and ascvd
-
3:26
achieving very low ldl-c levels with the pcsk9 inhibitor evolocumab
-
1:00:44
beyond statins: limitations of statin therapy and emerging alternatives
-
2:39:39
no cholesterol, no coronary heart disease : fact or fiction ?
-
3:41
cost-effectiveness of pcsk9 inhibitors for heterozygous fh or ascvd
-
1:00:28
breaking down the barriers to pcsk9 inhibitor use in clinically appropriate patients
-
1:04:42
cholesterol and cardiovascular disease in 2018: part 2
-
3:56
experience with pcsk9 inhibitors with dr. dufour
-
13:18
new era in cholesterol-lowering? pcsk9 inhibitors soon available?
-
23:43
lipidology - b.s. lewis
-
17:23
lipidology
-
3:40
osler trials suggest pcsk9 inhibitor reduces cardiovascular events long term
-
6:00
scientific insights into ldl-c, pcsk9, and cv risks
-
1:07
the role of cholesterol-lowering pcsk9 inhibitors